Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Samy Hadjadj and Ronan Roussel.
Connection Strength

1.395
  1. Use of dipeptidyl peptidase-4 inhibitors and prognosis of COVID-19 in hospitalized patients with type 2 diabetes: A propensity score analysis from the CORONADO study. Diabetes Obes Metab. 2021 05; 23(5):1162-1172.
    View in: PubMed
    Score: 0.232
  2. Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes. Cardiovasc Diabetol. 2018 08 02; 17(1):110.
    View in: PubMed
    Score: 0.195
  3. Prognostic Values of Inflammatory and Redox Status Biomarkers on the Risk of Major Lower-Extremity Artery Disease in Individuals With Type 2 Diabetes. Diabetes Care. 2018 10; 41(10):2162-2169.
    View in: PubMed
    Score: 0.195
  4. Investigation of the human ANP gene in type 1 diabetic nephropathy: case-control and follow-up studies. Diabetes. 2004 May; 53(5):1394-8.
    View in: PubMed
    Score: 0.073
  5. Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study. Diabetologia. 2021 04; 64(4):778-794.
    View in: PubMed
    Score: 0.058
  6. Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19. Diabetes Metab. 2021 09; 47(5):101216.
    View in: PubMed
    Score: 0.057
  7. Correction to: Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020 09; 63(9):1953-1957.
    View in: PubMed
    Score: 0.056
  8. Blood glucose levels and COVID-19. Reply to Sardu C, D'Onofrio N, Balestrieri ML et al [letter] and Lepper PM, Bals R, Jüni P et al [letter]. Diabetologia. 2020 11; 63(11):2491-2494.
    View in: PubMed
    Score: 0.056
  9. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020 08; 63(8):1500-1515.
    View in: PubMed
    Score: 0.055
  10. Prognostic value of plasma MR-proADM vs NT-proBNP for heart failure in people with type 2 diabetes: the SURDIAGENE prospective study. Diabetologia. 2018 12; 61(12):2643-2653.
    View in: PubMed
    Score: 0.049
  11. Sex Difference In the Effect of Fetal Exposure to Maternal Diabetes on Insulin Secretion. J Endocr Soc. 2018 05 01; 2(5):391-397.
    View in: PubMed
    Score: 0.048
  12. Plasma proprotein-convertase-subtilisin/kexin type 9 (PCSK9) and cardiovascular events in type 2 diabetes. Diabetes Obes Metab. 2018 04; 20(4):943-953.
    View in: PubMed
    Score: 0.047
  13. T-cadherin gene variants are associated with nephropathy in subjects with type 1 diabetes. Nephrol Dial Transplant. 2017 12 01; 32(12):2144.
    View in: PubMed
    Score: 0.047
  14. T-cadherin gene variants are associated with nephropathy in subjects with type 1 diabetes. Nephrol Dial Transplant. 2017 Dec 01; 32(12):1987-1993.
    View in: PubMed
    Score: 0.047
  15. Plasma concentrations of 8-hydroxy-2'-deoxyguanosine and risk of kidney disease and death in individuals with type 1 diabetes. Diabetologia. 2018 04; 61(4):977-984.
    View in: PubMed
    Score: 0.046
  16. Association of impaired renal function with venous thrombosis: A genetic risk score approach. Thromb Res. 2017 Oct; 158:102-107.
    View in: PubMed
    Score: 0.046
  17. Urinary lysophopholipids are increased in diabetic patients with nephropathy. J Diabetes Complications. 2017 Jul; 31(7):1103-1108.
    View in: PubMed
    Score: 0.045
  18. Urinary Sodium Concentration Is an Independent Predictor of All-Cause and Cardiovascular Mortality in a Type 2 Diabetes Cohort Population. J Diabetes Res. 2017; 2017:5327352.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.